Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders

Status:
Completed

Trial end date:
2010-09-01

Target enrollment:

Participant gender:

This was a randomized, active-controlled, double-blind, cross-over study designed to enroll subjects with UCDs who are being treated with NaPBA.

Phase 3

Horizon Pharma Ireland, Ltd., Dublin Ireland

4-phenylbutyric acid
Glycerol